SCNX Scienture Holdings, Inc.
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The …
Industry Peers
Pharmaceutical Retailers| Headline | Source | Time |
|---|---|---|
Older | ||
 SCIENTURE Launches REZENOPY as Second FDA-Approved Commercial Product SCIENTURE has commercially launched REZENOPY, its 10 mg naloxone nasal spray, and fulfilled initial purchase orders to U. S. | ||
 EXCLUSIVE: Scienture Launches Highest-Dose Naloxone Nasal Spray Rezenopy in US Pharmaceutical firm Scienture Holdings, Inc. (NASDAQ:SCNX) on Wednesday officially initiated the commercial rollout of Rezenopy, a 10-milligram naloxone hydrochloride nasal spray. The company has successfully fulfilled its initial purchase orders to pharmaceutical wholesalers across the U.S. The release marks a significant growth milestone for the holding company, representing the nationwide distribution of its second product to receive federal regulatory approval. Tackling High-Potency Syntheti | ||